Cartesian Therapeutics | 8-K: Current report
Cartesian Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-FMR LLC(3.925%),Abigail P. Johnson(3.925%)
Cartesian Therapeutics | 10-Q: Quarterly report
Cartesian Therapeutics | 8-K: Cartesian Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update
Cartesian Therapeutics | DEF 14A: Definitive information statements
Cartesian Therapeutics | DEFA14A: Others
Cartesian Therapeutics | 8-K: Current report
Cartesian Therapeutics | 3: Initial statement of beneficial ownership of securities-Officer English Emily
Cartesian Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Timothy A. Springer(36.4%),TAS Partners LLC(11.8%), etc.
Cartesian Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Singer Michael
Cartesian Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Kalayoglu Murat
Cartesian Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director SPRINGER TIMOTHY A
Cartesian Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Jewell Christopher M
Cartesian Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Miljkovic Milos
Cartesian Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Kurtoglu Metin
Cartesian Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Murat Kalayoglu(19.9%),Seven One Eight Three Four Irrevocable Trust(17.1%), etc.
Cartesian Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Michael Singer(4.3%),Baharak Asefzadeh(2.6%), etc.
Cartesian Therapeutics | 4: Statement of changes in beneficial ownership of securities-10% Owner Hoge Elizabeth
Cartesian Therapeutics | 8-K: Current report
Cartesian Therapeutics | 8-K: Current report
No Data